Banca
Pharmaceuticals and Healthcare Reports China Dyslipidemia Market Clique para ler
  • Comentários

Pharmaceuticals and Healthcare Reports

China Dyslipidemia Market

Publicado no e em "Saúde & Fitness, Saúde & Fitness", idioma — English. 3 páginas.
More so than in any other market, the statins dominated Chinese dyslipidemia drugs sales in the 2013 base year, contributing 84% to the total market share, reflecting sales of $1.7 billion in total sales Mais
Baixar
Assine GRÁTIS

Outras publicação de "Pharmaceuticals and Healthcare Reports"

Ver todas as publicações

Revistas Relacionadas